Skip to main content

Table 2 Characteristics of patients included in the immunoblot study

From: Reduced sphingosine kinase-1 and enhanced sphingosine 1-phosphate lyase expression demonstrate deregulated sphingosine 1-phosphate signaling in Alzheimer’s disease

Variable Controls (N = 3) AD patients (N = 4)
Age at death (years)   
 Median [IQR] 73.0 [69.0-92.0] 73.0 [72.0-73.0]
 Range 69.0-92.0 72.0, 89.0
Sex – n of patients (%)   
 Female 1 (33.3) 2 (50.0)
 Male 2 (66.6) 2 (50.0)
Post mortem interval   
 Median [IQR] 36.5 [10.0-63.0] 56.5 [44.0-59.0]
 Range 10.0-63.0 44.0, 59.0
 Missing (n) 1  
Braak Stage – n of patients (%)   
 0 2 (66.6)  
 II 1 (33.3)  
 VI   4 (100.0)
Thal – n of patients (%)   
 0 3 (100.0)  
 4   1 (25.0)
 5   3 (75.0)